GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,900,000 | -0.5% | 43,642 | -0.5% | 0.19% | +14.9% |
| Q1 2022 | $1,910,000 | -3.6% | 43,841 | -2.4% | 0.17% | +0.6% |
| Q4 2021 | $1,981,000 | +11.3% | 44,931 | -3.5% | 0.17% | +1.2% |
| Q3 2021 | $1,780,000 | -9.0% | 46,579 | -5.2% | 0.16% | -7.8% |
| Q2 2021 | $1,957,000 | +7.3% | 49,148 | -3.8% | 0.18% | +0.6% |
| Q1 2021 | $1,824,000 | -11.8% | 51,113 | -9.0% | 0.18% | -16.0% |
| Q4 2020 | $2,068,000 | -7.2% | 56,197 | -5.0% | 0.21% | -17.2% |
| Q3 2020 | $2,228,000 | -5.5% | 59,184 | +2.4% | 0.26% | -12.3% |
| Q2 2020 | $2,358,000 | +6.9% | 57,803 | -0.7% | 0.29% | -9.3% |
| Q1 2020 | $2,206,000 | -18.8% | 58,211 | +0.7% | 0.32% | +1.6% |
| Q4 2019 | $2,716,000 | +17.4% | 57,798 | +6.7% | 0.32% | +5.3% |
| Q3 2019 | $2,313,000 | +8.4% | 54,191 | +1.7% | 0.30% | +5.2% |
| Q2 2019 | $2,133,000 | +5.0% | 53,308 | +9.7% | 0.29% | +0.4% |
| Q1 2019 | $2,031,000 | +20.1% | 48,612 | +9.8% | 0.28% | +8.0% |
| Q4 2018 | $1,691,000 | +2.7% | 44,259 | +8.0% | 0.26% | +15.3% |
| Q3 2018 | $1,646,000 | +7.1% | 40,981 | +7.5% | 0.23% | 0.0% |
| Q2 2018 | $1,537,000 | +3.9% | 38,128 | +0.7% | 0.23% | +2.7% |
| Q1 2018 | $1,479,000 | +9.3% | 37,849 | -0.8% | 0.22% | +12.6% |
| Q4 2017 | $1,353,000 | -19.6% | 38,136 | -8.0% | 0.20% | -23.0% |
| Q3 2017 | $1,683,000 | -7.8% | 41,456 | -2.1% | 0.26% | -9.5% |
| Q2 2017 | $1,825,000 | +0.9% | 42,328 | -1.3% | 0.28% | -1.4% |
| Q1 2017 | $1,809,000 | +9.6% | 42,900 | +0.1% | 0.29% | +4.0% |
| Q4 2016 | $1,651,000 | -29.2% | 42,872 | -20.7% | 0.28% | -29.2% |
| Q3 2016 | $2,332,000 | -0.7% | 54,078 | -0.2% | 0.39% | -0.5% |
| Q2 2016 | $2,348,000 | +6.4% | 54,175 | -0.4% | 0.39% | +3.7% |
| Q1 2016 | $2,206,000 | -0.3% | 54,397 | -0.8% | 0.38% | -4.8% |
| Q4 2015 | $2,212,000 | +4.2% | 54,819 | -0.7% | 0.40% | -2.9% |
| Q3 2015 | $2,122,000 | -3.3% | 55,191 | +4.8% | 0.41% | +5.9% |
| Q2 2015 | $2,194,000 | -9.7% | 52,688 | +0.1% | 0.39% | -8.9% |
| Q1 2015 | $2,430,000 | +16.0% | 52,654 | +7.5% | 0.42% | +16.1% |
| Q4 2014 | $2,094,000 | +11.1% | 48,990 | +19.6% | 0.37% | +6.4% |
| Q3 2014 | $1,884,000 | -5.9% | 40,977 | +9.4% | 0.34% | -6.3% |
| Q2 2014 | $2,003,000 | +17.6% | 37,458 | +17.5% | 0.37% | +14.0% |
| Q1 2014 | $1,703,000 | +1.9% | 31,866 | +1.8% | 0.32% | +1.3% |
| Q4 2013 | $1,672,000 | +5.8% | 31,316 | -0.5% | 0.32% | -2.8% |
| Q3 2013 | $1,580,000 | +16.1% | 31,488 | +15.6% | 0.33% | +9.4% |
| Q2 2013 | $1,361,000 | – | 27,230 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |